Teva and Mylan are looking over their shoulders this morning after the FDA gave Novartis and Momenta the green light for their Copaxone copycat drug. Source: BioSpace

The FDA approved Vertex's Symdeko for cystic fibrosis in patients ages 12 and older with two copies of the F508del mutation. Source: BioSpace

The company plans to add approximately 100 positions at the Center by 2020. Source: BioSpace

The acquisition will strengthen Charles River's position as a global early-stage CRO, expanding its client base and service portfolio. Source: BioSpace

Bob Hugin announced his campaign on Monday in an email. Source: BioSpace

The Branford, CT-based company was founded in 2017 and plans to list on the Nasdaq under the symbol BTAI. Source: BioSpace

That announcement is a big change in the way Purdue has aggressively marketed OxyContin in the past. Source: BioSpace

AmerisourceBergen is one of the biggest drug distributors in the U.S. Source: BioSpace